Literature DB >> 27567577

Risk Factors for the Recurrent Herniation After Microendoscopic Discectomy.

Yuan Yao1, Huan Liu1, Huiyu Zhang2, Honggang Wang1, Zhengfeng Zhang1, Yangyi Zheng1, Yu Tang3, Yue Zhou4.   

Abstract

BACKGROUND: Microendoscopic discectomy (MED) has been widely accepted for its advantage of minimal injury in the treatment of lumbar disc herniation. Recurrence after successful MED has been reported; however, the risk factors responsible for the MED recurrence were still unclear.
METHODS: From April 2005 to April 2016, 111 patients with recurrent herniation after successful MED were included in this retrospective study. Kaplan-Meier methods and Cox regression analysis were used to identify the significant risk factors responsible for MED recurrence.
RESULTS: Univariate analysis demonstrated that age (≥50 years old), obesity (body mass index [BMI] ≥25), the treatment period (April 2005 to October 2010), modic change, nonmigrated herniation, and central herniation are identified as the potential risk factors for percutaneous endoscopic lumbar discectomy recurrence. Multivariate analysis suggested that age (≥50 years old), obesity (BMI ≥25), and modic change are identified as the significant risk factors responsible for MED recurrence.
CONCLUSIONS: Age (≥50 years old) was the most robust risk factor for MED recurrence. Obesity (BMI ≥25) and modic change were also highly involved in the recurrent herniation after successful MED. Taking these risk factors into consideration before surgery may be instrumental in pursuing a personalized operative method, which may lead to a more satisfactory operative outcome and a relatively lower recurrence rate.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Microendoscopic discectomy; Recurrent herniation; Risk factor

Mesh:

Year:  2016        PMID: 27567577     DOI: 10.1016/j.wneu.2016.08.071

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  7 in total

1.  The effect of short (2-weeks) versus long (6-weeks) post-operative restrictions following lumbar discectomy: a prospective randomized control trial.

Authors:  Christopher M Bono; Dana A Leonard; Thomas D Cha; Joseph H Schwab; Kirkham B Wood; Mitchel B Harris; Andrew J Schoenfeld
Journal:  Eur Spine J       Date:  2016-11-02       Impact factor: 3.134

2.  Incidence of early postoperative complications requiring surgical revision for recurrent lumbar disc herniation after spinal surgery: a retrospective observational study of 9,310 patients from the German Spine Register.

Authors:  Juan Manuel Vinas-Rios; Martin Sanchez-Aguilar; Fatima Azucena Medina Govea; Viktor Von Beeg-Moreno; Frerk Meyer
Journal:  Patient Saf Surg       Date:  2018-05-21

3.  Risk Factors and Surgical Treatment for Recurrent Lumbar Disc Prolapse: A Review of the Literature.

Authors:  Bharat R Dave; Devanand Degulmadi; Ajay Krishnan; Shivanand Mayi
Journal:  Asian Spine J       Date:  2019-10-15

4.  Percutaneous endoscopic lumbar discectomy compared with other surgeries for lumbar disc herniation: A meta-analysis.

Authors:  Xiaoliang Bai; Yong Lian; Jie Wang; Hongxin Zhang; Meichao Jiang; Hao Zhang; Bo Pei; Changqing Hu; Qiang Yang
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

5.  The Essence of Clinical Practice Guidelines for Lumbar Disc Herniation, 2021: 5. Prognosis.

Authors:  Hiromitsu Toyoda
Journal:  Spine Surg Relat Res       Date:  2022-07-27

6.  Recurrent lumbar disc herniation recurrence after percutaneous endoscopic lumbar discectomy: A case report.

Authors:  Yuanyi Wang; Cong Ning; Feng Xu; Yipeng Xiang; Liyu Yao; Yadong Liu; Wenjing Zhang; Xiuying Huang; Changfeng Fu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

7.  Nomograms for Predicting Recurrent Herniation in PETD with Preoperative Radiological Factors.

Authors:  Chong Zhao; Hao Zhang; Yan Wang; Derong Xu; Shuo Han; Shengwei Meng; Jialuo Han; Houchen Liu; Chuanli Zhou; Xuexiao Ma
Journal:  J Pain Res       Date:  2021-07-09       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.